Your session is about to expire
← Back to Search
Paclitaxel +/- Carboplatin for Breast Cancer
Study Summary
This trial is looking at whether paclitaxel with or without carboplatin is more effective in treating stage IV breast cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Find a Location
Who is running the clinical trial?
Media Library
- I am not currently responding to hormone therapy.My condition worsened after initially responding to hormone therapy.My condition worsened without having hormone therapy.My breast cancer diagnosis was confirmed through lab tests.My liver tests are within the required range.My kidney function is within the required range and my calcium levels are not too high.My heart is generally healthy with no recent major issues.I do not have any serious infections.My brain cancer has not worsened and I've finished radiation therapy at least 4 weeks ago.I do not have severe numbness or pain in my hands or feet.I don't have any serious health issues that would stop me from joining the study.My cancer's hormone receptor status is not determined.I am not currently on any cancer immunotherapy treatments.I am not receiving any radiotherapy, except for pain relief in bones.My cancer is not HER2 positive or its HER2 status is unknown.I have never been treated with Herceptin.I have not had chemotherapy for breast cancer that has spread.I am able to get out of my bed or chair and move around.I am either before or after menopause.I am female.It has been over 6 months since my last pre-surgery treatment.My condition is at stage IV, indicating it has spread to other parts of my body.It has been over 3 weeks since my last radiotherapy (or 4 weeks for brain treatment).I am not taking any other cancer treatments.It has been over 3 weeks since my last major surgery.My cancer is only in my bones.I am not currently taking any cancer hormone treatments.I am 18 years old or older.I haven't had radiation on 30% or more of my bone marrow.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
On how many continents is this research being conducted?
"Currently, this trial is being conducted at 25 sites across the country. If you are considering participating in this study, please choose the location nearest to you from the list of locations below to minimize travel time and expenses."
Are people able to sign up for this clinical trial at this time?
"Unfortunately, this particular trial is not looking for new participants at the moment. According to the clinicaltrials.gov website, this study was first posted on 01/01/2001 and was last edited on 07/23/2008. Although this specific research project isn't recruiting right now, there are 2,695 other trials that are currently accepting patients."
Does this medication have the FDA's blessing?
"There is some clinical data supporting the efficacy of this treatment and it has received multiple rounds of safety testing, so we have given it a score of 3."
Share this study with friends
Copy Link
Messenger